Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Medical Distribution

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goody`s analgesic powders, Boudreaux`s Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. It also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden`s cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer`s Eve feminine hygiene, Fess nasal saline spray, and Hydralyte for oral rehydration products. The company sells through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Website: prestigebrands.com


  • Bad financial results growth rate -5.8% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (-0.7%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield -0.3% (LTM)
  • Share price is 0.8% higher than minimum and 49.0% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (9.1x vs 30.0x)
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $0.1 mln (-0.005% of cap.)

Key Financials (Download financials)

Ticker: PBH
Share price, USD:  (+0.3%)45.44
year average price 65.53  


year start price 84.62 2025-06-05

max close price 86.64 2025-06-10

min close price 45.08 2026-06-04

current price 45.44 2026-06-05
Common stocks: 47 880 000

Dividend Yield:  0.0%
FCF Yield LTM: -0.3%
EV / LTM EBITDA: 9.1x
EV / EBITDA annualized: 8.9x
Last revenue growth (y/y):  -2.4%
Last growth of EBITDA (y/y):  -9.1%
Historical revenue growth:  -0.1%
Historical growth of EBITDA:  -1.3%
EV / Sales: 2.9x
Margin (EBITDA LTM / Revenue): 31.9%

Target EV / EBITDA (hist percentile): 30.0x
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 2 176
Net Debt ($m): 1 032
EV (Enterprise Value): 3 208
EBITDA LTM (млн $): 352
EV / LTM EBITDA: 9.1x
Price to Book: 1.2x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-02-05zacks.com

Prestige Consumer Healthcare (PBH) Q3 Earnings Lag Estimates

2026-02-05globenewswire.com

Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results

2026-01-23zacks.com

PBH vs. A: Which Stock Is the Better Value Option?

2026-01-02zacks.com

Is This the Right Time to Add PBH Stock to Your Portfolio?

2025-12-17zacks.com

PBH vs. ABT: Which Stock Should Value Investors Buy Now?

2025-12-01zacks.com

PBH or ABT: Which Is the Better Value Stock Right Now?

2025-11-06seekingalpha.com

Prestige Consumer Healthcare Inc. (PBH) Q2 2026 Earnings Call Transcript

2025-10-06globenewswire.com

Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results

2025-09-05seekingalpha.com

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript

2025-08-25seekingalpha.com

Premium Brands: Long Climb To $10 Billion
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-03-31
symbol PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-02-08 2023-11-02 2023-08-03 2023-02-02 2022-11-03
acceptedDate 2025-11-06 06:11:07 2025-08-07 06:15:06 2025-05-09 06:06:00 2024-11-07 06:11:01 2024-08-08 06:10:00 2024-05-15 07:01:05 2024-02-08 06:10:27 2023-11-02 06:11:44 2023-08-03 06:27:14 2023-05-05 16:08:25 2023-02-02 06:11:42 2022-11-03 06:37:20 2022-05-06 16:20:12 2021-05-07 16:17:38
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 274M 250M 1 138M 284M 267M 1 125M 283M 286M 279M 1 128M 276M 289M 1 087M 943M
costOfRevenue 120M 114M 503M 126M 127M 501M 125M 126M 125M 502M 125M 128M 466M 396M
grossProfit 154M 135M 634M 157M 140M 624M 158M 160M 155M 625M 150M 161M 621M 547M
grossProfitRatio 0.562 0.542 0.555 0.525 0.559 0.559 0.554 0.546 0.557
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 28M 28M 108M 26M 29M 106M 26M 26M 28M 107M 27M 26M 107M 83M
sellingAndMarketingExpenses 39M 35M 156M 41M 39M 153M 39M 40M 36M 145M 30M 44M 157M 141M
sellingGeneralAndAdministrativeExpenses 67M 63M 264M 67M 68M 259M 65M 66M 64M 252M 57M 70M 265M 224M
otherExpenses 8M 0 34M 6M -496 000 23M -682 000 -229 000 1M 395M 6M 6M 26M 26M
operatingExpenses 74M 63M 298M 73M 68M 282M 71M 72M 69M 648M 63M 77M 291M 250M
costAndExpenses 194M 178M 801M 199M 195M 783M 196M 198M 194M 1 150M 188M 205M 757M 646M
interestIncome 0 0 0 0 0 0 17M 18M 0 0 0 0 0 0
interestExpense 10M 10M 48M 12M 13M 67M 17M 18M 18M 69M 18M 17M 64M 82M
depreciationAndAmortization 8M 8M 30M 6M 8M 31M 8M 6M 8M 33M 7M 7M 32M 30M
ebitda 87M 80M 362M 90M 80M 374M 94M 94M 94M 8M 94M 92M 359M 317M
ebitdaratio 0.317 0.319 0.316 0.3 0.332 0.327 0.336 0.342 0.317
operatingIncome 80M 72M 337M 84M 72M 342M 87M 88M 85M -22M 87M 84M 330M 297M
operatingIncomeRatio 0.291 0.288 0.297 0.27 0.307 0.308 0.305 0.316 0.292
totalOtherIncomeExpensesNet -11M -10M -53M -13M -14M -66M -682 000 -229 000 1M -72M -19M -18M -67M -93M
incomeBeforeTax 69M 62M 284M 72M 58M 276M 70M 70M 69M -94M 68M 67M 262M 204M
incomeBeforeTaxRatio 0.252 0.248 0.253 0.219 0.246 0.246 0.246 0.247 0.23
incomeTaxExpense 27M 14M 70M 17M 9M 67M 17M 17M 15M -12M 16M 16M 57M 39M
netIncome 42M 47M 215M 54M 49M 209M 53M 54M 53M -82M 52M 51M 205M 165M
netIncomeRatio 0.154 0.19 0.192 0.184 0.188 0.187 0.191 0.189 0.176
eps 0.86 0.96 4.32 1.1 0.98 4.21 1.07 1.08 1.07 -1.65 1.05 1.02 4.09 3.28
epsdiluted 0.86 0.95 1.09 0.98 1.06 1.07 1.06 1.04 1.02
weightedAverageShsOut 49M 49M 50M 50M 50M 50M 50M 50M 50M 50M 50M 50M 50M 50M
weightedAverageShsOutDil 49M 50M 50M 50M 50M 50M 50M 50M 50M 50M 50M 50M 51M 51M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-05-09 2024-05-15 2023-05-05 2022-05-06 2021-05-07
fiscalYear 2025 2024 2023 2022 2021
netInterestIncome -48M -67M -69M -64M -82M
ebit 332M 343M -25M 327M 286M
nonOperatingIncomeExcludingInterest 5M -756 000 2M 3M 11M
netIncomeFromContinuingOperations 215M 209M -82M 205M 165M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 215M 209M -82M 205M 165M
epsDiluted 4.29 4.17 -1.65 4.04 3.25

Balance Sheet Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-03-31
symbol PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-02-08 2023-11-02 2023-08-03 2023-02-02 2022-11-03
acceptedDate 2025-11-06 06:11:07 2025-08-07 06:15:06 2025-05-09 06:06:00 2024-11-07 06:11:01 2024-08-08 06:10:00 2024-05-15 07:01:05 2024-02-08 06:10:27 2023-11-02 06:11:44 2023-08-03 06:27:14 2023-05-05 16:08:25 2023-02-02 06:11:42 2022-11-03 06:37:20 2022-05-06 16:20:12 2021-05-07 16:17:38
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 119M 140M 98M 52M 34M 46M 64M 60M 55M 58M 86M 42M 27M 32M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 119M 140M 98M 52M 34M 46M 64M 60M 55M 58M 86M 42M 27M 32M
netReceivables 199M 168M 194M 164M 172M 177M 174M 158M 158M 167M 157M 146M 139M 115M
inventory 159M 153M 148M 156M 152M 139M 149M 161M 170M 162M 159M 141M 120M 115M
otherCurrentAssets 20M 19M 8M 9M 11M 13M 7M 8M 9M 4M 7M 8M 0 0
totalCurrentAssets 497M 481M 448M 381M 369M 375M 394M 388M 392M 392M 409M 337M 293M 270M
propertyPlantEquipmentNet 122M 125M 128M 84M 86M 89M 83M 86M 87M 90M 91M 93M 99M 103M
goodwill 528M 528M 527M 529M 528M 528M 528M 527M 527M 528M 577M 576M 579M 578M
intangibleAssets 2 291M 2 295M 2 295M 2 317M 2 318M 2 321M 2 329M 2 328M 2 336M 2 342M 2 670M 2 671M 2 697M 2 476M
goodwillAndIntangibleAssets 2 819M 2 823M 2 823M 2 846M 2 846M 2 848M 2 856M 2 855M 2 864M 2 869M 3 247M 3 247M 3 276M 3 054M
longTermInvestments 0 0 0 0 -409M 0 -397M -388M -384M 0 0 0 0 0
taxAssets 0 0 0 0 409M 0 397M 388M 384M 0 456M 0 0 0
otherNonCurrentAssets 3M 3M 3M 7M 6M 6M 6M 4M 3M 3M -453M 3M 3M 3M
totalNonCurrentAssets 2 945M 2 951M 2 954M 2 936M 2 939M 2 943M 2 946M 2 945M 2 954M 2 962M 3 341M 3 342M 3 377M 3 159M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 3 442M 3 432M 3 402M 3 317M 3 308M 3 318M 3 340M 3 333M 3 346M 3 354M 3 750M 3 679M 3 671M 3 429M
accountPayables 42M 22M 19M 31M 40M 39M 39M 44M 58M 63M 64M 56M 56M 46M
shortTermDebt 9M 9M 0 3M 9M 0 8M 10M 9M 0 10M 9M 0 0
taxPayables 0 5M 830 000 104 000 189 000 3M 6M 8M 10M 11M 7M 12M 3M 4M
deferredRevenue 0 0 0 0 189 000 0 0 0 0 0 0 0 0 0
otherCurrentLiabilities 84M 73M 14M 73M 65M 57M 80M 76M 80M 14M 86M 87M 20M 14M
totalCurrentLiabilities 135M 110M 107M 107M 114M 117M 127M 130M 147M 161M 160M 152M 143M 122M
longTermDebt 1 032M 1 034M 992M 1 058M 1 098M 1 126M 1 206M 1 270M 1 326M 1 346M 1 438M 1 454M 1 477M 1 480M
deferredRevenueNonCurrent 0 0 0 0 7M 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 427M 420M 0 409M 404M 397M 388M 384M 380M 456M 443M 445M 434M
otherNonCurrentLiabilities 450M 5M 5M 420M 5M 9M 9M 9M 8M 8M 9M 1 841M 7M 9M
totalNonCurrentLiabilities 1 483M 1 466M 1 461M 1 478M 1 513M 1 546M 1 612M 1 667M 1 718M 1 746M 1 903M 1 906M 1 950M 1 949M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 48M 50M 52M 9M 12M 14M 14M 16M 19M 21M 24M 25M 30M 35M
totalLiabilities 1 617M 1 576M 1 567M 1 585M 1 627M 1 663M 1 739M 1 797M 1 865M 1 907M 2 063M 2 059M 2 093M 2 071M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 562 000 561 000 560 000 0 557 000 555 000 553 000 552 000 552 000 548 000 548 000 547 000 544 000 540 000
retainedEarnings 1 645M 1 603M 1 556M 1 445M 1 390M 1 341M 1 292M 1 239M 1 185M 1 132M 1 372M 1 320M 1 214M 1 009M
accumulatedOtherComprehensiveIncomeLoss -32M -32M -38M -27M -31M -34M -29M -36M -32M -32M -29M -36M -19M -20M
othertotalStockholdersEquity 211M 284M 314M 321M 337M 333M 327M 343M 335M
totalStockholdersEquity 1 825M 1 855M 1 835M 1 732M 1 681M 1 655M 1 601M 1 536M 1 480M 1 447M 1 687M 1 620M 1 578M 1 358M
totalEquity 1 825M 1 855M 1 835M 1 732M 1 681M 1 655M 1 601M 1 536M 1 480M 1 447M 1 687M 1 620M 1 578M 1 358M
totalLiabilitiesAndStockholdersEquity 3 442M 3 432M 3 317M 3 308M 3 340M 3 333M 3 346M 3 750M 3 679M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 3 442M 3 432M 3 402M 3 317M 3 308M 3 318M 3 340M 3 333M 3 346M 3 354M 3 750M 3 679M 3 671M 3 429M
totalInvestments 0 0 0 0 -409M 0 -397M -388M -384M 0 0 0 0 0
totalDebt 1 041M 1 043M 1 044M 1 061M 1 103M 1 140M 1 214M 1 279M 1 335M 1 367M 1 448M 1 464M 1 506M 1 515M
netDebt 922M 903M 946M 1 009M 1 069M 1 093M 1 150M 1 219M 1 281M 1 309M 1 361M 1 421M 1 479M 1 482M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-05-09 2024-05-15 2023-05-05 2022-05-06 2021-05-07
fiscalYear 2025 2024 2023 2022 2021
accountsReceivables 186M 177M 163M 139M 115M
otherReceivables 9M 0 4M 52 000 0
prepaids 0 0 0 6M 8M
totalPayables 20M 42M 73M 58M 50M
otherPayables 830 000 3M 11M 3M 4M
accruedExpenses 64M 12M 63M 56M 50M
capitalLeaseObligationsCurrent 9M 6M 10M 9M 8M
capitalLeaseObligationsNonCurrent 43M 8M 12M 21M 27M
treasuryStock -277M -220M -189M -134M -131M
additionalPaidInCapital 593M 567M 535M 516M 500M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-03-31
symbol PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-02-08 2023-11-02 2023-08-03 2023-02-02 2022-11-03
acceptedDate 2025-11-06 06:11:07 2025-08-07 06:15:06 2025-05-09 06:06:00 2024-11-07 06:11:01 2024-08-08 06:10:00 2024-05-15 07:01:05 2024-02-08 06:10:27 2023-11-02 06:11:44 2023-08-03 06:27:14 2023-05-05 16:08:25 2023-02-02 06:11:42 2022-11-03 06:37:20 2022-05-06 16:20:12 2021-05-07 16:17:38
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome 42M 47M 215M 54M 49M 209M 53M 54M 53M -82M 52M 51M 205M 165M
depreciationAndAmortization 8M 8M 30M 8M 8M 31M 8M 8M 8M 33M 8M 8M 32M 30M
deferredIncomeTax 17M 6M 0 -612 000 612 000 23M 5M 5M 4M -61M 10M 3M 10M 19M
stockBasedCompensation 2M 4M 11M 2M 3M 14M 2M 4M 4M 12M 2M 3M 9M 9M
changeInWorkingCapital -14M 12M -42M -622 000 -9M -40M 18 000 -11M -23M -54M -20M -11M -11M -6M
accountsReceivables -30M 27M -16M 9M 6M -6M -11M -1M 6M -25M -9M -1M -25M 37M
inventory -6M -4M -9M -3M -13M 24M 14M 8M -8M -42M -17M -7M 663 000 3M
accountsPayables 20M 3M -19M -8M 591 000 -25M -5M -13M -6M 7M 8M -2M 9M -17M
otherWorkingCapital 2M -14M 3M 2M -3M -33M 3M -4M -16M 6M -2M -620 000 4M -28M
otherNonCashItems 3M 2M 38M 7M 28M 12M 3M 3M 2M 382M 3M 3M 14M 19M
netCashProvidedByOperatingActivities 57M 79M 252M 70M 55M 249M 71M 62M 48M 230M 55M 58M 260M 236M
investmentsInPropertyPlantAndEquipment -2M -838 000 -8M -2M -1M -10M -2M -3M -1M -8M -2M -2M -10M -22M
acquisitionsNet 0 0 -9M 0 0 -11M 0 0 0 -4M 0 0 -247M 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites -827 000 -1M 0 -978 000 -3M 0 4M 0 0
netCashUsedForInvestingActivites -3M -2M -2M -2M -4M -3M 2M -2M -2M
debtRepayment -539 000 -608 000 -41M -36M -66M -56M -31M -16M -36M
commonStockIssued 752 000 0 0 0 2M 2M 0 0 0
commonStockRepurchased -75M -35M -52M -12M -26M -25M 0 0 -25M -50M 0 -12M 0 -12M
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -162 000 -899 000 2M -4M -769 000 2M 2M 6M 0
netCashUsedProvidedByFinancingActivities -75M -36M -51M -66M -65M -54M -54M -10M -48M
effectOfForexChangesOnCash -4000 825 000 -573 000 711 000 663 000 180 000 1M -490 000 -140 000 -982 000 798 000 -635 000 -959 000 4M
netChangeInCash -20M 42M 51M 17M -12M -12M 4M 5M -4M 31M 44M 7M -5M -62M
cashAtEndOfPeriod 119M 140M 98M 52M 34M 46M 64M 60M 55M 58M 86M 42M 27M 32M
cashAtBeginningOfPeriod 140M 98M 46M 34M 46M 58M 60M 55M 58M 27M 42M 36M 32M 95M
operatingCashFlow 57M 79M 252M 70M 55M 249M 71M 62M 48M 230M 55M 58M 260M 236M
capitalExpenditure -2M -838 000 -8M -2M -1M -10M -2M -3M -1M -8M -2M -2M -10M -22M
freeCashFlow 55M 78M 243M 68M 54M 239M 69M 60M 47M 222M 53M 55M 250M 213M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-05-09 2024-05-15 2023-05-05 2022-05-06 2021-05-07
fiscalYear 2025 2024 2023 2022 2021
otherInvestingActivities 0 0 0 0 0
netCashProvidedByInvestingActivities -17M -20M -12M -257M -22M
netDebtIssuance -140M -228M -138M -6M -251M
longTermNetDebtIssuance -140M -228M -138M -6M -196M
shortTermNetDebtIssuance 0 0 0 0 -55M
netStockIssuance -37M -25M -50M 0 -12M
netCommonStockIssuance -37M -25M -50M 0 -12M
commonStockIssuance 15M 0 0 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -6M 12M 2M -2M -16M
netCashProvidedByFinancingActivities -182M -241M -186M -8M -279M
incomeTaxesPaid 52M 60M 41M 47M 34M
interestPaid 48M 63M 54M 61M 80M

Earning call transcript

2025 q4
2026-02-05 ET (fiscal 2026 q3)
2025 q3
2025-11-06 ET (fiscal 2026 q2)
2025 q2
2025-08-08 ET (fiscal 2026 q1)
2025 q1
2025-05-11 ET (fiscal 2025 q4)
2024 q4
2025-02-06 ET (fiscal 2025 q3)
2024 q3
2024-11-09 ET (fiscal 2025 q2)
2024 q2
2024-08-08 ET (fiscal 2025 q1)
2024 q1
2024-05-15 ET (fiscal 2024 q4)
2023 q4
2024-02-08 ET (fiscal 2024 q3)
2023 q3
2023-11-04 ET (fiscal 2024 q2)
2023 q2
2023-08-05 ET (fiscal 2024 q1)
2023 q1
2023-05-06 ET (fiscal 2023 q4)
2022 q4
2023-02-02 ET (fiscal 2023 q3)
2022 q3
2022-11-06 ET (fiscal 2023 q2)
2022 q2
2022-08-07 ET (fiscal 2023 q1)
2022 q1
2022-05-06 ET (fiscal 2022 q4)
2021 q4
2022-02-03 ET (fiscal 2022 q3)
2021 q2
2021-08-07 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-05-13 20:30 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium Health
2026-04-30 12:00 ET
Prestige Consumer Healthcare to Release Fiscal 2026 Fourth Quarter and Year-End Earnings Results
2026-02-05 11:00 ET
Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results
2026-01-12 ET
Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference
2025-11-06 ET
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results
2025-10-06 ET
Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results
2025-09-04 ET
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
2025-08-07 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results
2025-07-15 ET
Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results
2025-06-17 ET
Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination
2025-06-09 ET
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
2025-05-08 ET
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
2025-04-10 ET
Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
2025-02-06 ET
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
2025-01-09 ET
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
2025-01-06 ET
Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities
2024-11-07 11:00 ET
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results
2024-10-08 12:00 ET
Prestige Consumer Healthcare to Release Fiscal 2025 Second Quarter Earnings Results
2024-09-03 12:00 ET
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
2024-07-02 20:30 ET
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
2024-06-06 20:30 ET
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
2024-05-14 21:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
2024-04-25 12:30 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
2024-04-03 15:57 ET
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
2024-04-03 15:57 ET
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
2024-02-08 11:00 ET
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
2024-02-02 14:00 ET
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
2024-01-10 22:00 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
2023-12-22 14:00 ET
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
2023-11-24 13:30 ET
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
2023-11-02 10:00 ET
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
2023-10-05 20:30 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
2023-09-05 21:00 ET
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
2023-08-03 10:00 ET
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
2023-07-11 12:00 ET
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results
2023-07-06 20:30 ET
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report
2023-06-05 13:00 ET
Prestige Consumer Healthcare to Present at Upcoming Investor Conferences
2023-05-31 13:00 ET
Goody’s® Introduces New “GET TO GOOD™” Marketing Campaign
2023-05-23 18:00 ET
Dramamine® Eases Americans’ Travel Woes with ‘Ditch the Drama’ Sweepstakes Offering a Vacation to Anywhere in the World
2023-05-04 10:00 ET
Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023
2023-04-18 12:00 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Fourth Quarter and Year-End Earnings Results
2023-02-02 11:00 ET
Prestige Consumer Healthcare Inc. Reports Third Quarter Results
2023-01-09 13:00 ET
Prestige Consumer Healthcare Inc. to Present at the 2023 ICR Conference
2023-01-05 21:30 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Third Quarter Earnings Results
2022-11-03 10:00 ET
Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023
2022-10-04 20:30 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Second Quarter Earnings Results
2022-09-07 21:03 ET
Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference
2022-08-04 10:00 ET
Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023
2022-07-11 20:30 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2023 First Quarter Earnings Results
2022-05-05 20:30 ET
Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022
2022-04-14 12:53 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Fourth Quarter and Year-End Earnings Results
2022-02-03 11:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results
2022-01-10 21:30 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Third Quarter Earnings Results
2021-11-04 10:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results
2021-10-06 20:30 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Second Quarter Earnings Results
2021-08-05 10:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 First Quarter Results
2021-07-01 20:01 ET
Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date
2021-05-27 12:30 ET
Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears
2021-05-06 10:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Fourth Quarter and Record Full-Year Results
2021-04-08 12:00 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Fourth Quarter and Year-End Earnings Results
2021-02-10 23:00 ET
Prestige Consumer Healthcare Inc. Announces Upsize and Pricing of $600 Million Senior Notes
2021-02-10 12:30 ET
Prestige Consumer Healthcare Inc. Announces Offering of $500 Million Senior Notes
2021-02-10 ET
Prestige Consumer Healthcare Inc. Announces Upsize and Pricing of $600 Million Senior Notes
2021-02-10 ET
Prestige Consumer Healthcare Inc. Announces Offering of $500 Million Senior Notes
2021-02-04 11:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Third Quarter Results
2021-01-08 13:30 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Third Quarter Earnings Results
2020-11-05 11:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Second Quarter Results
2020-10-07 21:00 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Second Quarter Earnings Results
2020-08-06 10:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 First Quarter Results
2020-07-13 20:45 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnings Results
2020-05-07 10:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Fourth Quarter and Full-Year Results
2020-04-27 12:00 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Fourth Quarter and Year-End Earnings Results
2020-03-02 11:30 ET
Prestige Consumer Healthcare Inc. Announces New $25 Million Share Repurchase Program, Participation in the Raymond James Institutional Investors Conference
2020-03-02 ET
Prestige Consumer Healthcare Inc. Announces New $25 Million Share Repurchase Program, Participation in the Raymond James Institutional Investors Conference
2020-02-06 11:00 ET
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Third Quarter and Year-to-Date Results
2020-01-06 23:00 ET
Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Third Quarter Earnings Results
2019-11-15 21:15 ET
Prestige Consumer Healthcare Inc. Announces Pricing of $400 Million Senior Notes
2019-11-15 12:35 ET
Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes
2019-11-15 ET
Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes
2019-11-15 ET
Prestige Consumer Healthcare Inc. Announces Pricing of $400 Million Senior Notes

SEC forms

Show financial reports only

SEC form 10
2026-05-14 20:32 ET
Prestige Consumer Healthcare published news for 2026 q1
SEC form 10
2026-02-05 06:09 ET
Prestige Consumer Healthcare reported for 2025 q4
SEC form 8
2026-02-05 06:04 ET
Prestige Consumer Healthcare published news for 2025 q4
SEC form 8
2026-02-05 06:04 ET
Prestige Consumer Healthcare published news for 2025 q4
SEC form 8
2026-02-05 06:04 ET
Prestige Consumer Healthcare published news for 2025 q4
SEC form 10
2025-11-06 06:11 ET
Prestige Consumer Healthcare reported for 2025 q3
SEC form 8
2025-11-06 06:03 ET
Prestige Consumer Healthcare published news for 2025 q3
SEC form 8
2025-11-06 06:03 ET
Prestige Consumer Healthcare published news for 2025 q3
SEC form 8
2025-11-06 06:03 ET
Prestige Consumer Healthcare published news for 2025 q3
SEC form 10
2025-08-07 10:15 ET
Prestige Consumer Healthcare reported for 2025 q2
SEC form 10
2025-05-09 10:06 ET
Prestige Consumer Healthcare published news for 2025 q1
SEC form 10
2025-05-09 00:00 ET
Prestige Consumer Healthcare published news for 2025 q1
SEC form 8
2025-05-08 10:04 ET
Prestige Consumer Healthcare published news for 2025 q1
SEC form 8
2025-05-08 10:04 ET
Prestige Consumer Healthcare reported for 2025 q1
SEC form 8
2025-05-08 10:04 ET
Prestige Consumer Healthcare published news for 2025 q1
SEC form 10
2025-02-06 06:08 ET
Prestige Consumer Healthcare reported for 2024 q4
SEC form 8
2025-02-06 06:03 ET
Prestige Consumer Healthcare published news for 2024 q4
SEC form 8
2025-02-06 06:03 ET
Prestige Consumer Healthcare published news for 2024 q4
SEC form 8
2025-02-06 06:03 ET
Prestige Consumer Healthcare published news for 2024 q4
SEC form 10
2025-02-06 00:00 ET
Prestige Consumer Healthcare published news for 2024 q4
SEC form 10
2024-11-07 06:11 ET
Prestige Consumer Healthcare published news for 2024 q3
SEC form 8
2024-11-07 06:03 ET
Prestige Consumer Healthcare published news for 2024 q3
SEC form 8
2024-11-07 06:03 ET
Prestige Consumer Healthcare published news for 2024 q3
SEC form 8
2024-11-07 06:03 ET
Prestige Consumer Healthcare published news for 2024 q3
SEC form 10
2024-08-08 06:10 ET
Prestige Consumer Healthcare reported for 2024 q2
SEC form 8
2024-08-08 06:03 ET
Prestige Consumer Healthcare published news for 2024 q2
SEC form 8
2024-08-08 06:03 ET
Prestige Consumer Healthcare published news for 2024 q2
SEC form 8
2024-08-08 06:03 ET
Prestige Consumer Healthcare published news for 2024 q2
SEC form 10
2024-08-08 00:00 ET
Prestige Consumer Healthcare published news for 2024 q2
SEC form 10
2024-05-15 00:00 ET
Prestige Consumer Healthcare published news for 2024 q1
SEC form 8
2024-05-14 17:04 ET
Prestige Consumer Healthcare published news for 2024 q1
SEC form 8
2024-05-14 17:04 ET
Prestige Consumer Healthcare published news for 2024 q1
SEC form 8
2024-05-14 17:04 ET
Prestige Consumer Healthcare published news for 2024 q1
SEC form 10
2024-02-08 00:00 ET
Prestige Consumer Healthcare reported for 2023 q4
SEC form 8
2024-02-08 00:00 ET
Prestige Consumer Healthcare published news for 2023 q4
SEC form 8
2024-02-08 00:00 ET
Prestige Consumer Healthcare published news for 2023 q4
SEC form 8
2024-02-08 00:00 ET
Prestige Consumer Healthcare published news for 2023 q4
SEC form 10
2023-11-02 06:11 ET
Prestige Consumer Healthcare reported for 2023 q3
SEC form 8
2023-11-02 06:06 ET
Prestige Consumer Healthcare published news for 2023 q3
SEC form 10
2023-11-02 00:00 ET
Prestige Consumer Healthcare published news for 2023 q3
SEC form 6
2023-08-03 14:00 ET
Prestige Consumer Healthcare published news for 2023 q2
SEC form 10
2023-08-03 06:27 ET
Prestige Consumer Healthcare reported for 2023 q2
SEC form 6
2023-08-03 06:15 ET
Prestige Consumer Healthcare published news for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Prestige Consumer Healthcare published news for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Prestige Consumer Healthcare published news for 2023 q2
SEC form 6
2023-06-29 16:05 ET
Prestige Consumer Healthcare published news for 2023 q1
SEC form 10
2023-05-05 00:00 ET
Prestige Consumer Healthcare published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Prestige Consumer Healthcare published news for 2023 q1
SEC form 10
2023-02-02 06:11 ET
Prestige Consumer Healthcare reported for 2022 q4
SEC form 6
2023-02-02 06:05 ET
Prestige Consumer Healthcare published news for 2022 q4
SEC form 10
2023-02-02 00:00 ET
Prestige Consumer Healthcare reported for 2022 q4
SEC form 8
2023-02-02 00:00 ET
Prestige Consumer Healthcare reported for 2022 q4
SEC form 10
2022-11-03 06:37 ET
Prestige Consumer Healthcare reported for 2022 q3
SEC form 6
2022-11-03 06:24 ET
Prestige Consumer Healthcare published news for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Prestige Consumer Healthcare reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Prestige Consumer Healthcare reported for 2022 q3
SEC form 10
2022-08-04 06:17 ET
Prestige Consumer Healthcare reported for 2022 q2
SEC form 6
2022-08-04 06:06 ET
Prestige Consumer Healthcare published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Prestige Consumer Healthcare reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Prestige Consumer Healthcare reported for 2022 q2
SEC form 6
2022-06-28 16:01 ET
Prestige Consumer Healthcare published news for 2022 q1
SEC form 10
2022-05-06 16:20 ET
Prestige Consumer Healthcare reported for 2022 q1
SEC form 10
2022-05-06 00:00 ET
Prestige Consumer Healthcare reported for 2022 q1
SEC form 6
2022-05-05 17:17 ET
Prestige Consumer Healthcare published news for 2022 q1
SEC form 8
2022-05-05 00:00 ET
Prestige Consumer Healthcare reported for 2022 q1
SEC form 10
2022-02-03 06:26 ET
Prestige Consumer Healthcare published news for 2021 q4
SEC form 6
2022-02-03 06:04 ET
Prestige Consumer Healthcare published news for 2021 q4
SEC form 10
2022-02-03 00:00 ET
Prestige Consumer Healthcare published news for 2021 q4
SEC form 8
2022-02-03 00:00 ET
Prestige Consumer Healthcare published news for 2021 q4
SEC form 10
2021-11-04 06:38 ET
Prestige Consumer Healthcare published news for 2021 q3
SEC form 6
2021-11-04 06:30 ET
Prestige Consumer Healthcare published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Prestige Consumer Healthcare published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Prestige Consumer Healthcare published news for 2021 q3
SEC form 10
2021-08-05 06:17 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 6
2021-08-05 06:04 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 6
2021-07-01 16:02 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 6
2021-06-29 06:03 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 6
2021-05-27 17:49 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 10
2021-05-07 16:17 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 6
2021-05-06 06:44 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 6
2021-05-05 16:26 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 6
2021-03-01 16:15 ET
Prestige Consumer Healthcare published news for 2020 q4
SEC form 10
2021-02-04 06:21 ET
Prestige Consumer Healthcare published news for 2020 q4
SEC form 6
2021-02-04 06:06 ET
Prestige Consumer Healthcare published news for 2020 q4
SEC form 10
2020-11-05 06:14 ET
Prestige Consumer Healthcare published news for 2020 q3
SEC form 6
2020-11-05 06:07 ET
Prestige Consumer Healthcare published news for 2020 q3